Women’s Health Focus Opportunity to partner on products and programs addressing reproductive health and diseases disproportionately impacting women, aligning with Organon’s global strategy to improve daily health of women.

Regional Expansion Recent cross-border partnerships in Southeast Asia (Malaysia, Philippines) with Hanmi indicate openness to distribution deals and co-developed therapies in new markets, suggesting potential channels for regional sales growth.

Strategic Partnerships Organon’s ongoing negotiations and potential integration with Sun Pharma could create broader distribution networks and consolidated debt considerations, presenting opportunities for supply chain collaborations and contract manufacturing discussions.

Digital & Data Enablement Adoption of modern tech stack including Power Automate, Collibra, SQL Server and AI tools signals readiness for data-driven sales initiatives, enabling targeted customer insights and streamlined regulatory/compliance processes.

Financial Signals Revenue scale and EBITDA indicators, along with notable litigation activity around biosimilars, suggest opportunities in high-value product portfolios and adjacent biosimilar strategies, with a need for strategic pricing and risk management discussions.